Free Trial

Indaptus Therapeutics (INDP) Insider Trading & Ownership

Indaptus Therapeutics logo
$0.94 +0.05 (+5.39%)
(As of 12/20/2024 05:31 PM ET)

Indaptus Therapeutics (NASDAQ:INDP) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
29.50%
Number Of
Insiders Buying
(Last 3 Years)
4
Amount Of
Insider Buying
(Last 3 Years)
$244,653.23
Number Of
Insiders Selling
(Last 3 Years)
1
Amount Of
Insider Selling
(Last 3 Years)
$29,350.00
Get INDP Insider Trade Alerts

Want to know when executives and insiders are buying or selling Indaptus Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

INDP Insider Buying and Selling by Quarter

Indaptus Therapeutics Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
8/14/2023Glen R AndersonMajor ShareholderBuy23,934$2.34$56,005.56  
8/10/2023Glen R AndersonMajor ShareholderBuy44,354$1.94$86,046.76  
12/1/2022Boyan Vesselinov LitchevInsiderBuy500$1.87$935.00  
11/22/2022Boyan Vesselinov LitchevInsiderBuy500$1.83$915.00  
11/21/2022Jeffrey A MecklerCEOBuy9,600$1.90$18,240.00  
11/18/2022Jeffrey A MecklerCEOBuy400$1.76$704.00  
9/8/2022Jeffrey A MecklerCEOBuy10,308$2.80$28,862.40  
9/7/2022Walt Addison LinscottInsiderBuy150$2.62$393.00  
6/6/2022Jeffrey A MecklerCEOBuy19,727$2.63$51,882.01  
3/2/2022Boyan Vesselinov LitchevInsiderBuy50$4.09$204.50  
1/31/2022Boyan Vesselinov LitchevInsiderBuy100$4.65$465.00  
1/31/2022Michael James NewmanDirectorSell5,870$5.00$29,350.00  
(Data available from 1/1/2013 forward)

INDP Insider Trading Activity - Frequently Asked Questions

The list of insiders at Indaptus Therapeutics includes Boyan Vesselinov Litchev, Glen R Anderson, Jeffrey A Meckler, Michael James Newman, and Walt Addison Linscott. Learn more on insiders at INDP.

29.50% of Indaptus Therapeutics stock is owned by insiders. Learn more on INDP's insider holdings.

The following insider purchased INDP shares in the last 24 months: Glen R Anderson ($142,052.32).

Insiders have purchased a total of 68,288 INDP shares in the last 24 months for a total of $142,052.32 bought.

Indaptus Therapeutics Key Executives

  • Mr. Jeffrey A. MecklerMr. Jeffrey A. Meckler (Age 57)
    CEO & Director
    Compensation: $867.03k
  • Dr. Michael J. Newman Ph.D. (Age 68)
    Founder, Chief Scientific Officer & Director
    Compensation: $659.99k
  • Mr. Walt Addison Linscott Esq. (Age 63)
    Chief Operating Officer
    Compensation: $716.35k
  • Mr. Nir Sassi (Age 48)
    CFO, Secretary & Treasurer
    Compensation: $378.47k
  • Dr. Roger J. Waltzman M.B.A. (Age 56)
    M.D., Chief Medical Officer


This page (NASDAQ:INDP) was last updated on 12/21/2024 by MarketBeat.com Staff
From Our Partners